ARCHIVES

DCCP Board Approves Concepts For Nearly $20 Million In Grants, Contracts, Including New Inhibitors Study

This article is from The Cancer Letter archive.

Vol. 09 No. 23 | June 10, 1983

Download PDF Visit The Full Archive

Related Articles

Slow Accruing Trials Should Be Removed From High Priority Program, Broder Says

October 2, 1992

NCI Plans $61 Million For Six-Year Program In Biomarker Research For Early Detection

December 4, 1998

Benefit Seen In Novel Drug That Treats Gleevec Resistance

April 29, 2005

Flavopiridol Plus Cisplatin Tested In Phase II Trial

October 26, 2007

Government Shutdown Cancels NCI Site Visit To Mayo Cancer Center

October 11, 2013

Referral Pattern Change Needed For Quality Care, AACR/ASCO Told

May 16, 1975